Mechanistic physiology-based pharmacokinetic modeling to elucidate vincristine-induced peripheral neuropathy following treatment with novel kinase inhibitors

PURPOSE: Limited information is available regarding the drug–drug interaction (DDI) potential of molecular targeted agents and rituximab plus cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (Oncovin), and prednisone (R-CHOP) therapy. The addition of the Bruton tyrosine kinase (BTK)...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilla Reddy , Venkatesh, Fretland, Adrian J., Zhou, Diansong, Sharma, Shringi, Chen, Buyun, Vishwanathan, Karthick, McGinnity, Dermot F., Xu, Yan, Ware, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316236/
https://www.ncbi.nlm.nih.gov/pubmed/34080039
http://dx.doi.org/10.1007/s00280-021-04302-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316236/
https://www.ncbi.nlm.nih.gov/pubmed/34080039
http://dx.doi.org/10.1007/s00280-021-04302-5

Ejemplares similares